Professor, Internal Medicine, University of Missouri, Columbia School of Medicine
Hematology
Dr. Carl E. Freter, MD
|
|
Give Review
Carl Freter is an expert in the field of Hematology. He went to Washington University School of Medicine in St. Louis. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Dr. Carl E. Freter is a published doctor and has 38 publications published. The lastest was: 'Sweet''s syndrome during treatment with all-trans retinoic acid in a patient with acute promyelocytic leukemia.' Carl Freter is registered with Medicare.
Publications
- Thromboprophylaxis and Incidence of Venous Thromboembolism in Patients With Hemophilia A or B Who Underwent High-Risk Orthopedic Surgeries.
- Cervical neuroendocrine tumor in a young female with Lynch Syndrome.
- Insight into Sweet's syndrome and associated-malignancy: A review of the current literature.
- Gemcitabine and cisplatin-induced tumor lysis syndrome in a patient with gallbladder Carcinoma: A case report.
- Iron Deficiency Anemia Related to Hereditary Hemorrhagic Telangiectasia: Response to Treatment With Bevacizumab.
- Plasma microRNAs as novel biomarkers for early detection of lung Cancer.
- Postoperative bleeding in an elderly patient from acquired factor V inhibitor: rapid response to immunosuppressive therapy.
- Lipid metabolism, apoptosis and Cancer therapy.
- Targeting cholesterol synthesis increases chemoimmuno-sensitivity in chronic lymphocytic Leukemia cells.
- Lung Cancer screening: from imaging to biomarker.
- Alemtuzumab in previously treated chronic lymphocytic Leukemia patients who also had received fludarabine.
- Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 Acute lymphocytic leukemia: results of cancer and leukemia group ...
- Dexamethasone and suramin inhibit Cell proliferation and interleukin-6-mediated immunoglobulin secretion in human lymphoid and multiple myeloma Cell lines.
- Effect of membrane sterol content on the susceptibility of phospholipids to phospholipase A2.
- Conditions influencing formation of 16:0/16:0 molecular species in membrane phospholipids of Escherichia coli.
- Doxorubicin cardiac toxicity manifesting seven years after treatment. Case report and review.
- Translocation t(11;22) in esthesioneuroblastoma.
- Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast Cancer: its regulation by estrogen and its possible functional signif...
- Alterations in phosphoinositide metabolism associated with 17 beta-estradiol and growth factor treatment of MCF-7 breast Cancer cells.
- Acquired immunodeficiency syndrome-associated Lymphomas.
- Phosphoinositide metabolism in human prostate Cancer cells in vitro.
- Anti-IgM-mediated growth inhibition of a human B lymphoma Cell line is independent of phosphatidylinositol turnover and protein kinase C activation and involves tyrosi...
- Mechanisms of inhibition of IL-6-mediated immunoglobulin secretion by dexamethasone and suramin in human lymphoid and myeloma Cell lines.
- Acquisition of hormone-independent growth in MCF-7 Cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications.
- Angioimmunoblastic lymphadenopathy with dysproteinemia.
- Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental Cancer cachexia in vivo.
- High circulating interleukin 6 levels associated with Acute transfusion reaction: cause or effect?
- Sterol depletion of LM Cells using chemical inhibitors and genetic defects. A comparison of secondary phospholipid alterations.
- Membrane phospholipid alterations in response to sterol depletion of LM Cells. Metabolic studies.
- Intravascular large Cell lymphoma coexisting within hemangiomas of the skin.
- Hodgkin's disease treated with neck radiation is associated with increased antibody-dependent Cellular cytotoxicity against human extraocular muscle Cells.
- Molecular detection of bone marrow involvement in intravascular Lymphomatosis.
- Hormonal carcinogenesis in breast Cancer: cellular and molecular studies of malignant progression.
- Modulation of signal transduction in phosphocholine-specific B Cells from mu kappa transgenic mice.
- A randomized phase 2 study of PBPC mobilization by stem Cell factor and filgrastim in heavily pretreated patients with Hodgkin''s disease or non-Hodgkin''s lymphoma.
- Sweet''s syndrome during treatment with all-trans retinoic acid in a patient with Acute promyelocytic leukemia.
- Ellis Fischel Cancer Center needs Missouri's support.
Schools
Washington University St Louis
Stanford University Med Center
National Institute Health
Procedures Preformed
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- American Enterprise Group
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Preferred Plus POS
- Blue Preferred Select
- Assurant Health
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- CHAMPVA
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Coventry Health Care
- Coventry Health Care of Illinois PPO
- Health and Life PPO
- Platinum PPO
- Coventry Health Care of Missouri PPO
- First Health (Coventry Health Care) PPO
- Group Health Cooperative
- HealthLink PPO
- Homestate Health Plan
- Choice Care PPO
- Mail Handlers Benefit Plan (MHBP)
- Medicaid
- Medicare MCR
- Medico
- Molina
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
National Institutes of Health Clinical Center -
Stanford University -
Washington University School of Medicine in St. Louis
Drug Facts
| NPI NUMBER | 1760594071 | |
| NPPES Provider LastName | FRETER | |
| NPPES Provider FirstName | CARL | |
| NPPES Provider ZIPCode | 652120001 | |
| NPPES Provider State | MO | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 1074.0 | |
| Distinct Opioid Count | 8.0 | |
| Opioid Claim Count | 201.0 | |
| Percent Opioid Claims | 18.72 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1760594071 |
| Last Name Of The Provider | FRETER |
| First Name Of The Provider | CARL |
| View All |
Similar Doctors
|
|
Dr. Michael C. Trendle, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark M. Tungesvik, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary S. Muscato, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shadi M. Haddadin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pamela J. Honeycutt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tamara V. Hopkins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Radwan F. Khozouz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William P. Patterson, MD |
|
|
Dr. Elangovan Balakrishnan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Puja Nistala, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael X. Wang, MD |